As of June 30, 2026, Roche Holding Ltd carries a market capitalization of 5.74T, placing it among publicly traded companies globally. Its enterprise value stands at 6.30T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.74T |
| Enterprise Value | 6.30T |
As of June 30, 2026, Roche Holding Ltd has 812.98M shares outstanding.
| Shares Outstanding | 812.98M |
These figures are as of June 30, 2026.
| PB Ratio | 8.12 |
| P/TBV Ratio | 47.36 |
As of June 30, 2026, Roche Holding Ltd maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.23 |
| Quick Ratio | 0.34 |
| Debt / Equity | 86.62 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 112,774.00 |
As of June 30, 2026, Roche Holding Ltd holds 210.53B in cash and equivalents against 687.87B in total debt, resulting in a net debt position of 570.04B. Total book value stands at 707.08B, with working capital of 142.53B providing operational flexibility.
| Cash & Cash Equivalents | 210.53B |
| Total Debt | 687.87B |
| Net Debt | 570.04B |
| Equity (Book Value) | 707.08B |
| Book Value Per Share | 869.74 |
| Working Capital | 142.53B |
Roche Holding Ltd's most recent stock split took place on May 4, 2001 with a 1:100 split ratio.
| Last Split Date | 5/4/2001 |
| Split Ratio | 1:100 |
Already premium?